Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 618 of 745

Advanced search

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07679009: Diagnostic Utility of Cardiac MRI

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07678112: Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07677930: Digital Insomnia and Circadian Therapy for Reducing Depression Symptoms in College Students

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07677852: Sexual and Urinary Dysfunctions in Generalized Myasthenia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07675876: Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07675213: Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07674745: Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07672444: [Trial of device that is not approved or cleared by the U.S. FDA]

Study type: . Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07664657: To Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets in Healthy Participants Under Fasting Conditions

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07304154: A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07240805: Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07229378: Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07173101: Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07139951: Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07045792: Body Awareness Therapy in High Stressed Young Adults: Effects on Function, Balance, Sleep and Mood

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT07010120: A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06956105: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06949046: Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06465199: Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06428409: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06422806: Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT06209385: A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT05987956: Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT05967533: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT05922930: Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT05616416: International Big Data Centre in Emergency Medicine

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT05472597: Continuation of the nuMoM2b Heart Health Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT04835805: A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT04677647: OurChild: A Health IT Solution to Reduce Minority Health Disparities

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT04214392: Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT04116970: Endobronchial Ultrasound-Guided Transbronchial Needle-Aspiration With Suction in Obtaining Samples From Patients With Suspected Nodal Metastatic Lung Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT03722407: Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT02829736: ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT02339571: A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 1Researchclinicaltrials.govTier 1 · Trial registry

NCT01927302: Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

Proactive financial newsOriginal source

🌍Jul 1Industryaptose.comTier 1 · Company source

Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical

Aptose BiosciencesOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

AI company Anthropic announces it will begin developing drugs of its own

statnews.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Korea boosts CMC to rescue drug approvals and cut overseas dependence - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 1Industryeledon.comTier 1 · Company source

Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes

Eledon PharmaceuticalsOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?

The Motley FoolOriginal source

🌍Jul 1Mediacryopak.comTier 2 · Direct publisher

Made in Canada: Why Local Cold Chain Manufacturing Matters

CryopakOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Pediatric clinical trial update: June 2026

Contemporary PediatricsOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Indonesia resumes shrimp exports to Saudi Arabia after import ban lifted

Vietnam+ (VietnamPlus)Original source

🇺🇸Jul 1CROir.labcorp.comTier 3 · Secondary coverage

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Labcorp Drug DevelopmentOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Delaware Judge Tosses Biotech Exec.'s $700M Suit Over Failed IPO

Law.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

RFK Jr. wants to make it easier to get peptides. FDA scientists disagree.

NBC NewsOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Anthropic releases Claude Science, a product aimed at researchers, the pharma industry

statnews.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy

Ophthalmology TimesOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Gerren McHam on the Future of US Pharma Reshoring

Pharmaceutical CommerceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

FDA Approves New TED Drug for Active and Chronic Phases

Review of OptometryOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

BIO 2026: Biotech Fundraising Rises As Company Pipelines Mature

insights.citeline.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

FDA Names Seven Participants to Precheck Program | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Ever Supreme Advances Off-the-Shelf CAR-T Therapy CAR001 to Phase IIa After Positive Phase I Safety Review

BioPharma APACOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

NPROriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

UMSOP Professor Richard Dalby Retires After 34 Years of Leadership in Pharmaceutical Sciences

The University of Maryland, BaltimoreOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Unicycive’s kidney disease drug

93.3 The DriveOriginal source

🇺🇸Jul 1Industrybioreference.comTier 1 · Company source

Men’s Health Month: An Opportunity to Strengthen Preventive Care Engagement

BioReference LaboratoriesOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Why Sellas Remains A Strong Sell After Doubling In Price (NASDAQ:SLS)

Seeking AlphaOriginal source